肺部康复在COVID-19后阻塞性呼吸器功能障碍患者中的积极影响
Gabriela-Marina Brînduș1, Eugenia-Andreea Marcu1, Mihai Olteanu2
1PhD Student, Doctoral School, University of Medicine and Pharmacy of Craiova, Romania.
Current health sciences journal
|June 12, 2023
概括
肺部康复治疗在COVID-19后阻塞性肺病患者的症状和功能显著改善. 这种方法对于管理感染后恢复和提高生活质量至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 康复医学 康复医学 康复医学
背景情况:
- 由SARS-CoV-2引起的COVID-19在2019年出现,导致全球大流行.
- 患有先前存在的阻塞性呼吸系统功能障碍的患者,如COPD或喘,患重症COVID-19的风险增加.
- 在SARS-CoV-2感染后的出院后症状包括疲劳,咳,呼吸困难和认知障碍.
研究的目的:
- 评估为期六个月的呼吸系统康复计划对从SARS-CoV-2感染中康复的患者的好处.
- 评估康复对有阻塞性肺部疾病病史的患者的影响.
主要方法:
- 这是一项追溯性研究,涉及72名患有SARS-CoV-2感染和阻塞性呼吸系统功能障碍 (喘或COPD) 的患者,这些患者从专门医院出院.
- 康复计划包括体力和肌肉训练,营养和心理支持以及患者教育.
- 患者在出院3个月和6个月后进行监测,以评估结果.
主要成果:
- 肺部康复导致COVID-19后患者的临床和功能参数得到改善.
- 关键的改善包括提高运动能力,减少呼吸困难,增加氧和.
结论:
- 肺部康复对于管理COVID-19患者,特别是COPD患者,改善运动能力,减少呼吸障碍和提高整体生活质量至关重要.
- 吸烟是SARS-CoV-2感染和阻塞性呼吸系统功能障碍的重要危险因素.
- 接种疫苗与较温和的COVID-19形式有关.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
01:26COPD: Management Using Bronchodilators and Corticosteroids
255
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
255
01:20COPD: Pathogenesis and Clinical Features
367
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
367
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
272
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
272
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K